Epigenetic modifications in cancer
Kanwal R, Gupta S. Epigenetic modifications in cancer. Cancer initiation and progression is
controlled by both genetic and epigenetic events. The complexity of carcinogenesis cannot …
controlled by both genetic and epigenetic events. The complexity of carcinogenesis cannot …
Aflatoxin B1-induced epigenetic alterations: An overview
Abstract Aflatoxin B1 (AFB1) is widely distributed in nature, especially in a variety of food
commodities. It is confirmed to be the most toxic of all the aflatoxins. The toxicity of AFB1 has …
commodities. It is confirmed to be the most toxic of all the aflatoxins. The toxicity of AFB1 has …
Epigenetic mechanisms and cancer: an interface between the environment and the genome
Z Herceg, T Vaissière - Epigenetics, 2011 - Taylor & Francis
Although epidemiological studies support the role of environment in a wide range of human
cancers, the precise mechanisms by which environmental exposures promote cancer …
cancers, the precise mechanisms by which environmental exposures promote cancer …
Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers
Background: Blood leukocytes from patients with solid tumors exhibit complex and distinct
cancer-associated patterns of DNA methylation. However, the biologic mechanisms …
cancer-associated patterns of DNA methylation. However, the biologic mechanisms …
The prognostic value of global DNA hypomethylation in cancer: a meta-analysis
Background Aberrant methylation of the global genome has been investigated as a
prognostic indicator in various cancers, but the results are controversial and ambiguous …
prognostic indicator in various cancers, but the results are controversial and ambiguous …
[HTML][HTML] PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
H Gevensleben, EE Holmes, D Goltz, J Dietrich… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Background The rapid development of programmed death 1 (PD-1)/programmed death
ligand 1 (PD-L1) inhibitors has generated an urgent need for biomarkers assisting the …
ligand 1 (PD-L1) inhibitors has generated an urgent need for biomarkers assisting the …
[HTML][HTML] Fecal DNA testing for colorectal cancer screening: the ColoSure™ test
RM Ned, S Melillo, M Marrone - PLoS currents, 2011 - ncbi.nlm.nih.gov
Colorectal cancer is the third most common cancer and the second leading cause of cancer-
related deaths in the United States. Screening has been shown to be effective in reducing …
related deaths in the United States. Screening has been shown to be effective in reducing …
[HTML][HTML] Epigenetically inactivated RASSF1A as a tumor biomarker
RASSF1A, one of the eight isoforms of the RASSF1 gene, is a tumor suppressor gene that
influences tumor initiation and development. In cancer, RASSF1A is frequently inactivated …
influences tumor initiation and development. In cancer, RASSF1A is frequently inactivated …
Introduction to epigenetics
Epigenetics is the study of inherited variations in gene expression that do not involve
changes to DNA sequences. Over 200 unique cell types in a human adult have a nearly …
changes to DNA sequences. Over 200 unique cell types in a human adult have a nearly …
[HTML][HTML] Epigenetics and testicular germ cell tumors
R Buljubašić, M Buljubašić, AK Bojanac, M Ulamec… - Gene, 2018 - Elsevier
Malignant testicular germ cell tumors (TGCTs) are the most frequent testicular cancers in
Caucasian males, developing at the most productive age of man. We are briefly reviewing …
Caucasian males, developing at the most productive age of man. We are briefly reviewing …